Total Payments
$389,416
2024 Payments
$19,728
Companies
61
Transactions
1,624
Medicare Patients
1,742
Medicare Billing
$750,964
Payment Breakdown by Category
Other$319,459 (82.0%)
Food & Beverage$28,402 (7.3%)
Consulting$22,559 (5.8%)
Travel$18,522 (4.8%)
Education$474.22 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $316,209 | 149 | 81.2% |
| Food and Beverage | $28,402 | 1,355 | 7.3% |
| Consulting Fee | $22,559 | 13 | 5.8% |
| Travel and Lodging | $18,522 | 95 | 4.8% |
| Honoraria | $3,250 | 2 | 0.8% |
| Education | $474.22 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $92,293 | 230 | $0 (2024) |
| Allergan, Inc. | $92,118 | 191 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $37,046 | 345 | $0 (2024) |
| Amgen Inc. | $31,629 | 66 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $23,585 | 25 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $19,947 | 46 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $19,819 | 52 | $0 (2019) |
| Lilly USA, LLC | $16,771 | 70 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $15,708 | 51 | $0 (2020) |
| Biohaven Pharmaceuticals, Inc. | $11,889 | 31 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,728 | 157 | ABBVIE INC. ($18,034) |
| 2023 | $23,554 | 126 | AbbVie Inc. ($22,560) |
| 2022 | $52,709 | 127 | ABBVIE INC. ($31,502) |
| 2021 | $64,458 | 117 | AbbVie Inc. ($20,176) |
| 2020 | $43,932 | 128 | Allergan, Inc. ($19,753) |
| 2019 | $66,198 | 369 | Allergan Inc. ($14,822) |
| 2018 | $69,918 | 320 | Allergan Inc. ($20,111) |
| 2017 | $48,918 | 280 | ACADIA Pharmaceuticals Inc ($23,124) |
All Payment Transactions
1,624 individual payment records from CMS Open Payments — Page 1 of 65
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/24/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: PAIN | ||||||
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PAIN | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $37.89 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/18/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: PAIN | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.04 | General |
| Category: Neuroscience | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 352 | 29,406 | $507,114 | $183,326 |
| 2022 | 9 | 407 | 29,024 | $512,167 | $182,690 |
| 2021 | 11 | 481 | 29,088 | $538,756 | $190,439 |
| 2020 | 11 | 502 | 31,954 | $572,590 | $194,508 |
Total Patients
1,742
Total Services
119,472
Medicare Billing
$750,964
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 46 | 28,870 | $375,310 | $139,769 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 163 | $39,609 | $13,008 | 32.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 29 | 93 | $27,156 | $9,570 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 99 | $17,028 | $5,264 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 35 | $12,005 | $4,076 | 33.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 12 | 35 | $14,040 | $4,033 | 28.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 23 | 44 | $8,228 | $2,846 | 34.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 18 | 53 | $7,844 | $2,796 | 35.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $5,894 | $1,964 | 33.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 47 | 28,447 | $369,811 | $136,179 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 180 | $43,684 | $13,934 | 31.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 30 | 81 | $23,652 | $8,692 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 132 | $22,674 | $6,387 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 49 | $16,777 | $5,556 | 33.1% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 12 | 33 | $14,560 | $4,162 | 28.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 22 | 40 | $7,465 | $2,965 | 39.7% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 17 | 46 | $6,808 | $2,477 | 36.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $6,736 | $2,340 | 34.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 47 | 28,400 | $369,200 | $132,566 | 35.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 151 | 215 | $51,789 | $17,496 | 33.8% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 29 | 86 | $24,842 | $8,809 | 35.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 108 | 137 | $23,224 | $7,411 | 31.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 42 | $14,272 | $5,222 | 36.6% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 14 | 41 | $18,858 | $5,033 | 26.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 27 | 54 | $10,174 | $4,007 | 39.4% |
About Dr. Warren Chumley, MD
Dr. Warren Chumley, MD is a Clinical Neurophysiology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902853617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warren Chumley, MD has received a total of $389,416 in payments from pharmaceutical and medical device companies, with $19,728 received in 2024. These payments were reported across 1,624 transactions from 61 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($316,209).
As a Medicare-enrolled provider, Chumley has provided services to 1,742 Medicare beneficiaries, totaling 119,472 services with total Medicare billing of $750,964. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Location Lexington, KY
- Active Since 05/28/2006
- Last Updated 05/05/2019
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1902853617
Products in Payments
- BOTOX (Biological) $85,576
- UBRELVY (Drug) $56,067
- Aimovig (Biological) $31,362
- QULIPTA (Drug) $24,792
- NUPLAZID (Drug) $23,585
- NURTEC ODT (Drug) $21,469
- INGREZZA (Drug) $19,835
- ACTHAR (Biological) $19,819
- AJOVY (Drug) $17,521
- TROKENDI XR (Drug) $15,657
- BOTOX (Drug) $14,427
- AJOVY (Biological) $14,245
- EMGALITY (Drug) $9,896
- VYEPTI (Biological) $5,396
- SOLIRIS (Drug) $4,546
- BOTOX CHRONIC MIGRAINE (Drug) $3,286
- COPAXONE (Drug) $662.02
- TYSABRI (Biological) $520.80
- AUSTEDO (Drug) $448.34
- KESIMPTA (Drug) $429.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Neurophysiology Doctors in Lexington
Dr. Greg Anderson, Md, MD
Clinical Neurophysiology — Payments: $44,121
Clinical Neurophysiology $44,121
Dr. Ima Ebong, Md, MD
Clinical Neurophysiology — Payments: $14,651
Clinical Neurophysiology $14,651
Stephen Ryan, Md, MD
Clinical Neurophysiology — Payments: $213.92
Clinical Neurophysiology $213.92
Kevin Nelson, Md, MD
Clinical Neurophysiology — Payments: $95.04
Clinical Neurophysiology $95.04